SEC Company Response from Entera Bio Ltd. (ENTX, ENTXW) (CIK 0001638097) (ENTX) — Jun 25, 2018
Entera Bio Ltd. (ENTX, ENTXW) (CIK 0001638097)
Date: June 25, 2018 · CIK: 0001638097 · Accession: 0000950103-18-007723
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-221472
Letter
MAXIM GROUP LLC
405 Lexington Avenue, 2nd floor
New York, NY 10174
June 25,
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: Entera Bio Ltd.
Registration Statement on Form F-1, as amended
File No. 333-221472
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Maxim Group LLC, as representative of the underwriters, hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 4:30 p.m. Eastern Time on June 27, 2018, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter, who is reasonably anticipated to be invited to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that they have complied with, or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced issue.
Very
truly yours,
Maxim Group LLC
Show Raw Text
CORRESP
1
filename1.htm
MAXIM
GROUP LLC
405 Lexington Avenue, 2nd floor
New
York, NY 10174
June 25,
2018
VIA EDGAR
United States Securities and Exchange
Commission
100 F Street, N.E.
Washington, D.C. 20549
Re:
Entera Bio Ltd.
Registration Statement on Form F-1, as amended
File No. 333-221472
Ladies and Gentlemen:
Pursuant to
Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933,
as amended, Maxim Group LLC, as representative of the underwriters, hereby requests acceleration of the effective date of the
above-referenced Registration Statement so that it will become effective at 4:30 p.m. Eastern Time on June 27, 2018, or as soon
thereafter as practicable.
Pursuant to
Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter, who is reasonably anticipated
to be invited to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus
as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned
confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating
dealers that they have complied with, or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934,
as amended, in connection with the above-referenced issue.
Very
truly yours,
Maxim Group LLC
By:
/s/
Clifford A. Teller
Name:
Clifford
A. Teller
Title:
Executive
Managing Director, Head of Investment Banking